Diabetes Ten City Challenge

Font Size A A A | Print Page

The Diabetes Ten City Challenge

The Diabetes Ten City Challenge (DTCC) is administered by the American Pharmacists Association Foundation (APhA). It is sponsored by GlaxoSmithKline. The primary focus is to support participating employers within ten cities to help manage diabetes within their covered populations. Modeled in part from The Asheville Project, the DTCC uses community pharmacists in assisting participants with their care plan.

How Does the Diabetes Ten City Challenge Work?

  • The APhA Foundation contracts with employers and helps establish a local pharmacist network within the community.
  • Employers offer a voluntary employee benefit with incentives. Pharmacists are compensated for care provided.
  • Participants use a proprietary APhA Foundation patient self-management program to educate patients and document progress.
  • Participants receive the benefit of collaborative teams that communicate regularly to optimize care:
    • Pharmacists
    • Diabetes educators
    • Physicians
  • Program success is measured by:
    • Improvements in blood sugar control
    • Patient satisfaction
    • Decreased medical costs

Initial Clinical Trends

Early clinical results within a small group of patients with ≥3 pharmacist visits and having high baseline HbA1c levels (>9%) and baseline LDL cholesterol levels >130 mg/dL have shown1:

  • 15% reduction in HbA1c levels
  • 32% decrease in LDL cholesterol
  • Over 50% of patients are still not currently meeting target blood pressure readings of <130/80 mm Hg. But the following goals are being established for every patient:
    • Nutrition
    • Weight Loss
    • Exercise
  • Improvements in compliance with eye and foot exams.
  • Improvements in compliance with influenza vaccine administration.

Learn more. Go to:www.aphafoundation.org or www.diabetestencitychallenge.com.

Reference:

  1. APhA Foundation. Summit report: The diabetes ten city challenge. Summer 2007.
This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Contact Us